Christopher Etherton-Beer is an Associate Professor in Geriatric Medicine at the University of Western Australia, and a Geriatrician and Clinical Pharmacologist at Royal Perth Hospital. Christopher serves on the Federal Council of the Australian and New Zealand Society for Geriatric Medicine, the Pharmaceutical Benefits Advisory Committee, and the Board of Juniper. Christopher is the immediate past Chair of the RACP Advanced Training Committee in Geriatric Medicine, and Chairs the Western Australian Therapeutics Advisory Group. Christopher has research interests in pharmaco-geriatrics, stroke, aged care and medical education.
Deprescribing is the process of withdrawal of an inappropriate medication, supervised by a health care professional with the goal of managing polypharmacy and improving outcomes (Reeve et al., Br J Clin Pharmacol 2015; 80:1254-68). Geriatricians frequently recommend deprescribing medicines for which the harms currently outweigh the benefits as part of their comprehensive geriatric assessments of frail older patients.
This breakfast session, presented by Profs Sarah Hilmer and Christopher Etherton-Beer, will present the emerging evidence on the risks and benefits of deprescribing, and on barriers to and enablers of implementing deprescribing in practice across a range of settings. It will focus on the role of the geriatrician as one of many health care providers for older people. The session aims to increase the knowledge and skills of the participants in deprescribing for their frail older patients.
Call for Abstracts open: 25th October 2016
Registration Opens: 18th November 2016
Call for Abstracts Closes: 24th February 2017
Notification of Abstracts: 20th March 2017
Close of Early Registration: 31st March 2017
Conference: 10th May 2017
Australian and New Zealand Society for Geriatric Medicine (ANZSGM)
145 Macquarie Street
Sydney NSW 2000, Australia
Tel: +61 2 9256 5460
Fax: +61 2 9241 3458